|
| | cycloheterophyllin Basic information |
| Product Name: | cycloheterophyllin | | Synonyms: | cycloheterophyllin;(+)-2,3,8-Trihydroxy-11,11-dimethyl-13-(3-methyl-2-butenyl)-6-(2-methyl-1-propenyl)-6H,7H,11H-bis[1]benzopyrano[4,3-b:6',7'-e]pyran-7-one;6H,7H,11H-Bis[1]benzopyrano[4,3-b:6',7'-e]pyran-7-one, 2,3,8-trihydroxy-11,11-dimethyl-13-(3-methyl-2-buten-1-yl)-6-(2-methyl-1-propen-1-yl)-, (+)- | | CAS: | 36545-53-6 | | MF: | C30H30O7 | | MW: | 502.55 | | EINECS: | | | Product Categories: | | | Mol File: | 36545-53-6.mol |  |
| | cycloheterophyllin Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | powder | | color | Yellow | | LogP | 8.120 (est) |
| | cycloheterophyllin Usage And Synthesis |
| Description | Cycloheterophyllin exerts a concentration-dependent inhibition of neutrophil cytosolic protein kinase C (PKC) and rat brain PKC by the O2- generation in rat neutrophils, but has no effect on porcine heart protein kinase A (PKA).
Cycloheterophyllin has an antioxidant effect and can effectively scavenge free radicals.
3. Cycloheterophyllin is a photoprotective agent that inhibits ultraviolet A (UVA)-induced oxidative stress and damage, and could be used in the research on and prevention of skin photoaging.
4. Cycloheterophyllin shows strong inhibition of arachidonic acid (AA)-induced platelet aggregation, due to an inhibitory effect on cyclooxygenase. | | Definition | ChEBI: Cycloheterophyllin is an extended flavonoid. | | target | PKA | PKC | NADPH-oxidase | NF-kB | Caspase | MAPK |
| | cycloheterophyllin Preparation Products And Raw materials |
|
